Inhibition Effect of Luteolin on the Proliferation and Migration of the Endothelial Cells Co-Cultured with Cancer Cells and Its Molecular Mechanism
PING Yao-dong1, LIANG Tai-gang2, ZHANG Yan-hua1*
1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Pharmacy of Department, Peking University Cancer Hospital & Institute, Beijing 100142, China; 2. College of Pharmacy, Shanxi Medical University, Taiyuan 030001, China
Abstract��OBJECTIVE To explore the effects of luteolin on the proliferation and migration of the endothelial cells co-cultured with cancer cells and its molecular mechanism. METHODS Human umbilical vein endothelial cells (HUVECs) were primarily isolated and identified by the expression of VE-cadherin. Cancer-endothelial cell co-culture model was established using the Transwell system. The effects of luteolin at different concentrations (0 [Co-culture control], 20 and 50 ��mol��L-1) on the proliferation and migration of HUVECs in the co-culture system were determined. A HUVECs control group removed of prostate cancer PC3 cells was also included. Human angiogenesis antibody array kit was used to assay the secretion levels of various protein factors in each group. RESULTS VE-cadherin was expressed on all the cultured HUVECs. Increased proliferation ability was found in the HUVECs co-cultured with PC3 cells compared with that in HUVECs control group (P<0.01). Treatment with 20 or 50 ��mol��L-1 luteolin significantly inhibited the proliferation ability of the HUVECs in co-culture system (both P<0.01). Increased migration ability was found in the HUVECs co-cultured with PC3 cells compared with that in HUVECs control group (P<0.01). Treatment with 20 or 50 ��mol��L-1 luteolin significantly inhibited the migration ability of the HUVECs in co-culture system (both P<0.01). Secretion levels of multiple angiogenesis-related proteins in the cultural supernatant of co-culture system were significantly increased compared with those in HUVECs control group. Treatment with 20 ��mol��L-1 luteolin significantly inhibited the secretion levels of interleukin-8 (IL-8), vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1(MCP-1) in the cultural supernatant of co-culture system (all P<0.01). CONCLUSION Luteolin may inhibit the proliferation and migration of endothelial cells via suppressing the secretions of IL-8, VEGF and MCP-1 in cancer-endothelial co-culture system.
ƽҫ��, ��̩��, ����. ľϬ����������ǰ���ٰ�PC3ϸ������������Ƥϸ����ֳ��Ǩ�Ƽ�����ӻ���[J]. �й�ҩѧ��־, 2018, 53(7): 508-512.
PING Yao-dong, LIANG Tai-gang, ZHANG Yan-hua. Inhibition Effect of Luteolin on the Proliferation and Migration of the Endothelial Cells Co-Cultured with Cancer Cells and Its Molecular Mechanism. Chinese Pharmaceutical Journal, 2018, 53(7): 508-512.
ZHANG J X, XING J G, WANG L L, et al. Luteolin inhibits fibrillary beta-amyloid1-40-induced inflammation in a human blood-brain barrier model by suppressing the p38 mapk-mediated nf-kappab signaling pathways [J]. Molecules, 2017, 22(3): 334-336.
[2]
LIU Y, HUANG J, ZHENG X, et al. Luteolin, a natural flavonoid, inhibits methylglyoxal induced apoptosis via the mtor/4e-bp1 signaling pathway [J]. Sci Rep, 2017, 7(1): 7877-7879.
[3]
ZANG M D, HU L, FAN Z Y, et al. Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the notch signaling pathway [J]. J Transl Med, 2017, 15(1): 52-53.
[4]
KANG K A, PIAO M J, RYU Y S, et al. Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells [J]. Int J Oncol, 2017, 51(4): 1169-1178.
[5]
ZANG M, HU L, ZHANG B, et al. Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting notch1-vegf signaling in gastric cancer [J]. Biochem Biophys Res Commun, 2017, 490(3): 913-919.
[6]
GEORGE V C, DELLAIRE G, RUPASINGHE H P V. Plant flavonoids in cancer chemoprevention: role in genome stability [J]. J Nutr Biochem, 2017, 45(1): 1-14.
[7]
BAUDIN B, BRUNEEL A, BOSSELUT N, et al. A protocol for isolation and culture of human umbilical vein endothelial cells [J]. Nat Protoc, 2007, 2(3): 481-485.
[8]
CHIEW G G, FU A, LOW K P, et al. Physical supports from liver cancer cells are essential for differentiation and remodeling of endothelial cells in a HepG2-HUVEC co-culture model [J]. Sci Rep, 2015, 5(1): 1080-1082.
[9]
HUSS W J, HANRAHAN C F, BARRIOS R J, et al. Angiogenesis and prostate cancer: identification of a molecular progression switch [J]. Cancer Res, 2001, 61(6): 2736-2743.
[10]
PAYTON S. Prostate cancer: galectin signature reveals gal-1 as key player in angiogenesis [J]. Nat Rev Urol, 2012, 9(12): 667-671.
[11]
MIYATA Y, OHBA K, MATSUO T, et al. Tumor-associated stromal cells expressing e-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesis [J]. Urology, 2013, 81(1): 136-142.
[12]
FERRANDO M, GUERON G, ELGUERO B, et al. Heme oxygenase 1 (ho-1)challenges the angiogenic switch in prostate cancer [J]. Angiogenesis, 2011, 14(4): 467-479.
[13]
BAGLI E, STEFANIOTOU M, MORBIDELLI L, et al. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3��-kinase activity [J]. Cancer Res, 2004, 64(21): 7936-7946.
[14]
SUI J Q, XIE K P, XIE M J. Inhibitory effect of luteolin on the proliferation of human breast cancer cell lines induced by epidermal growth factor [J]. Acta Physiol Sin(����ѧ��), 2016, 68(1): 27-34.
[15]
CAI X, LU W, YE T, et al. The molecular mechanism of luteolin-induced apoptosis is potentially related to inhibition of angiogenesis in human pancreatic carcinoma cells [J]. Oncol Rep, 2012, 28(4): 1353-1361.
[16]
KIM J A, KIM D K, KANG O H, et al. Inhibitory effect of luteolin on tnf-alpha-induced il-8 production in human colon epithelial cells [J]. Int Immunopharmacol, 2005, 5(1): 209-217.
[17]
LI W F,ZHOU K, ZHAO Z B.Inhibition effect of luteolin on IL-8 signal path inbreast cancer cells MDA MB 231[J]. Chin J Adv Gen Sure(�й��ִ���ͨ��ƽ�չ), 2014, 17(6): 435-438.
[18]
DING H, LI D, ZHANG Y, et al. Luteolin inhibits smooth muscle cell migration and proliferation by attenuating the production of nox4, p-akt and vegf in endothelial cells [J]. Curr Pharm Biotechnol, 2014, 14(12): 1009-1015.
[19]
WU S H, LOU Y,HUANG L. Progress of in the mechanism of monocyte chemoattractant protein-1[J]. Chin J Clin(Elect Ed)(�л��ٴ�ҽʦ��־���Ӱ�), 2012, 6(10): 2773-2775.
[20]
BHARDWAJ S, ROY H, BABU M, et al. Adventitial gene transfer of vegfr-2 specific vegf-e chimera induces mcp-1 expression in vascular smooth muscle cells and enhances neointimal formation [J]. Atherosclerosis, 2011, 219(1): 84-91.
2018, Vol. 53 
